- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03050788
Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kampala, Uganda
- Infectious Diseases Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
i. ≥ 18 years old ii. Clinically suspected KS iii. Presence of suspected KS lesions in areas which are considered safe to biopsy by the Ugandan providers, which means all areas of the skin except for the mouth and eye.
Exclusion Criteria:
i. Presence of suspected KS lesions exclusively on the mouth or eye unless clinical specialists trained in biopsy of the mouth or eye are available locally to biopsy the mouth or eye. Oral and eye sites would typically only be biopsied when clinical diagnosis has proved to be problematic and definitive diagnosis is needed to inform a treatment plan.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Smartphone confocal microscopy imaging
Subject's skin lesion will be imaged with the smartphone confocal microscopy.
|
Imaging of skin lesion using the smartphone confocal microscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of diagnosing Kaposi sarcoma using the smartphone confocal microscopy
Time Frame: Approximately 20 minutes (10 minutes for in vivo imaging)
|
Confocal microscopy images obtained from the skin lesion will be compared with the corresponding histologic images.
Diagnostic accuracy will be tested.
No clinical decisions will be made based on confocal microscopy images.
|
Approximately 20 minutes (10 minutes for in vivo imaging)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dongkyun Kang, PhD, Massachusetts General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016P002672
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kaposi Sarcoma
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruitingClassic Kaposi Sarcoma | Kaposi Sarcoma | Refractory Kaposi Sarcoma
-
Assistance Publique - Hôpitaux de ParisUnknownKaposi' s Sarcoma | Classic Kaposi' s Sarcoma | Endemic Kaposi' s Sarcoma | Lymph Angio ProliferationsFrance
-
National Cancer Institute (NCI)National Institute of Allergy and Infectious Diseases (NIAID)WithdrawnClassic Kaposi Sarcoma | AIDS-related Kaposi Sarcoma
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of California, Los Angeles; Montefiore... and other collaboratorsCompletedSkin Kaposi Sarcoma | Recurrent Kaposi SarcomaUnited States, Uganda, South Africa
-
National Cancer Institute (NCI)CompletedAIDS-related Kaposi Sarcoma | Recurrent Kaposi SarcomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCWithdrawnHIV Infection | AIDS-related Kaposi Sarcoma | Recurrent Kaposi Sarcoma
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Cancer Immunotherapy Trials Network (CITN)TerminatedHIV Infection | Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Not yet recruitingKaposi Sarcoma | HIV-1-infection | AIDS-related Kaposi Sarcoma
Clinical Trials on Smartphone confocal microscopy
-
Johns Hopkins UniversityAmerican Society for Gastrointestinal Endoscopy; Pentax Medical CorporationCompletedBarrett's Esophagus, Esophageal Intraepithelial NeoplasiaUnited States, Germany
-
Singapore General HospitalCompletedDiffuse Parenchymal Lung DiseasesSingapore
-
Nantes University HospitalInstitut de Recherche en Santé Respiratoire des Pays de la LoireCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedMicrocirculation | Blood CirculationFrance
-
Memorial Sloan Kettering Cancer CenterRecruitingHead and Neck Cancer | Squamous Cell Carcinoma (SCC) of the Oral CavityUnited States
-
Julie DawsonCompletedBasal Cell CarcinomaUnited Kingdom
-
Technical University of MunichCharite University, Berlin, Germany; Technische Universität DresdenCompleted
-
Lucid, Inc.Memorial Sloan Kettering Cancer Center; University of Rochester; Loma Linda University and other collaboratorsCompletedMelanoma | Skin Cancer | Lentigo MalignaUnited States
-
Institut de Cancérologie de LorraineRecruitingSquamous Cell Carcinoma of Head and Neck | Basal Cell Carcinoma of SkinFrance